SIMILASAN Troubles du sommeil glob 15 g

7680513600374 CH-51360 20.01.1.
SIMILASAN Troubles du sommeil glob 15 g
google

Details

Product number
5136001
CPT
-
Packaging group
15
Unit
g
Composition
avena sativa (HAB) D12 2.500 mg, hepar sulfuris (HAB) D12 2.500 mg, pulsatilla pratensis (HAB) D15 2.500 mg, zincum isovalerianicum (HAB) D12 2.500 mg, calcii carbonas, xylitolum, ad globulos pro 1 g corresp. 70-90 granula homoeopathica imbuta.

Articles (1)

Similasan Schlafstörungen, Globuli
Globuli
15
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/05/2022
Patient information leaflet
Français
18/05/2022
Patient information leaflet
Italien
18/05/2022

Detailed composition

Substance Quantity Type Category
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
51360
Drug name
Similasan Schlafstörungen, Globuli
Galenic form
GLO
Authorization status
Z
Dispensation category
D
First authorization
14/08/1991
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei Ein- und Durchschlafstörungen

Packaging details

Description (FR)
SIMILASAN Troubles du sommeil glob 15 g
Description (DE)
SIMILASAN Schlafstörungen Glob 15 g
Market launch
14/08/1991
Narcotic (BTM)
No

Other packaging sizes